Hippocampal-Dependent Inhibitory Learning and Memory Processes in the Control of Eating and Drug Taking

Author:

Clasen Matthew M.1,Riley Anthony L.2ORCID,Davidson Terry L.2ORCID

Affiliation:

1. Department of Psychology, Program in Neuroscience, Williams College, Williamstown, MA 01267, United States

2. Department of Neuroscience, Center for Behavioral Neuroscience, American University, Washington, DC 20016, United States

Abstract

As manifestations of excessive and uncontrolled intake, obesity and drug addiction have generated much research aimed at identifying common neuroadaptations that could underlie both disorders. Much work has focused on changes in brain reward and motivational circuitry that can overexcite eating and drug-taking behaviors. We suggest that the regulation of both behaviors depends on balancing excitation produced by stimuli associated with food and drug rewards with the behavioral inhibition produced by physiological “satiety” and other stimuli that signal when those rewards are unavailable. Our main hypothesis is that dysregulated eating and drug use are consequences of diet- and drug-induced degradations in this inhibitory power. We first outline a learning and memory mechanism that could underlie the inhibition of both food and drug-intake, and we describe data that identifies the hippocampus as a brain substrate for this mechanism. We then present evidence that obesitypromoting western diets (WD) impair the operation of this process and generate pathophysiologies that disrupt hippocampal functioning. Next, we present parallel evidence that drugs of abuse also impair this same learning and memory process and generate similar hippocampal pathophysiologies. We also describe recent findings that prior WD intake elevates drug self-administration, and the implications of using drugs (i.e., glucagon-like peptide- 1 agonists) that enhance hippocampal functioning to treat both obesity and addiction are also considered. We conclude with a description of how both WD and drugs of abuse could initiate a “vicious-cycle” of hippocampal pathophysiology and impaired hippocampal-dependent behavioral inhibition.

Funder

National Institutes of Health

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference249 articles.

1. Ogden C.L.; Carroll M.D.; Lawman H.G.; Fryar C.D.; Kruszon-Moran D.; Kit B.K.; Flegal K.M.; Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016,315(21),2292-2299

2. Ng M.; Fleming T.; Robinson M.; Thomson B.; Graetz N.; Margono C.; Mullany E.C.; Biryukov S.; Abbafati C.; Abera S.F.; Abraham J.P.; Abu-Rmeileh N.M.; Achoki T.; AlBuhairan F.S.; Alemu Z.A.; Alfonso R.; Ali M.K.; Ali R.; Guzman N.A.; Ammar W.; Anwari P.; Banerjee A.; Barquera S.; Basu S.; Bennett D.A.; Bhutta Z.; Blore J.; Cabral N.; Nonato I.C.; Chang J.C.; Chowdhury R.; Courville K.J.; Criqui M.H.; Cundiff D.K.; Dabhadkar K.C.; Dandona L.; Davis A.; Dayama A.; Dharmaratne S.D.; Ding E.L.; Durrani A.M.; Esteghamati A.; Farzadfar F.; Fay D.F.; Feigin V.L.; Flaxman A.; Forouzanfar M.H.; Goto A.; Green M.A.; Gupta R.; Hafezi-Nejad N.; Hankey G.J.; Harewood H.C.; Havmoeller R.; Hay S.; Hernandez L.; Husseini A.; Idrisov B.T.; Ikeda N.; Islami F.; Jahangir E.; Jassal S.K.; Jee S.H.; Jeffreys M.; Jonas J.B.; Kabagambe E.K.; Khalifa S.E.; Kengne A.P.; Khader Y.S.; Khang Y.H.; Kim D.; Kimokoti R.W.; Kinge J.M.; Kokubo Y.; Kosen S.; Kwan G.; Lai T.; Leinsalu M.; Li Y.; Liang X.; Liu S.; Logroscino G.; Lotufo P.A.; Lu Y.; Ma J.; Mainoo N.K.; Mensah G.A.; Merriman T.R.; Mokdad A.H.; Moschandreas J.; Naghavi M.; Naheed A.; Nand D.; Narayan K.M.; Nelson E.L.; Neuhouser M.L.; Nisar M.I.; Ohkubo T.; Oti S.O.; Pedroza A.; Prabhakaran D.; Roy N.; Sampson U.; Seo H.; Sepanlou S.G.; Shibuya K.; Shiri R.; Shiue I.; Singh G.M.; Singh J.A.; Skirbekk V.; Stapelberg N.J.; Sturua L.; Sykes B.L.; Tobias M.; Tran B.X.; Trasande L.; Toyoshima H.; van de Vijver S.; Vasankari T.J.; Veerman J.L.; Velasquez-Melendez G.; Vlassov V.V.; Vollset S.E.; Vos T.; Wang C.; Wang X.; Weiderpass E.; Werdecker A.; Wright J.L.; Yang Y.C.; Yatsuya H.; Yoon J.; Yoon S.J.; Zhao Y.; Zhou M.; Zhu S.; Lopez A.D.; Murray C.J.; Gakidou E.; Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014,384(9945),766-781

3. Bose J.; Hedden S.L.; Lipari R.N.; Key substance use and mental health indicators in the United States: results from the 2017 national survey on drug use and health 2018

4. Peacock A.; Leung J.; Larney S.; Colledge S.; Hickman M.; Rehm J.; Giovino G.A.; West R.; Hall W.; Griffiths P.; Ali R.; Gowing L.; Marsden J.; Ferrari A.J.; Grebely J.; Farrell M.; Degenhardt L.; Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 2018,113(10),1905-1926

5. Blum K.; Thanos P.K.; Gold M.S.; Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol 2014,5,919-930

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3